NCT03803072 is a NA clinical trial of time restricted eating (TRE) in Diabetes, Gestational, sponsored by Norwegian University of Science and Technology.

Who is sponsoring NCT03803072?

NCT03803072 is sponsored by Norwegian University of Science and Technology.

What drugs are being tested in NCT03803072?

Interventions in NCT03803072: time restricted eating (TRE).

What condition does NCT03803072 study?

NCT03803072 studies Diabetes, Gestational.

Is NCT03803072 still recruiting?

NCT03803072 is currently completed. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT03803072

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Novel Diet Approach to Combat Gestational Diabetes

Completed NA Last updated 16 March 2023

What this trial tests

NA trial testing time restricted eating (TRE) in Diabetes, Gestational in 32 participants. Completed in 15 March 2023.

Timeline

18 January 2019

Primary endpoint
13 March 2023

15 March 2023

Quick facts

Lead sponsor	Norwegian University of Science and Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	32
Start date	18 January 2019
Primary completion	13 March 2023
Estimated completion	15 March 2023
Sites	1 location across Norway

Drugs / interventions tested

time restricted eating (TRE)

Conditions studied

Diabetes, Gestational — all drugs for Diabetes, Gestational →

Sponsor

Norwegian University of Science and Technology

Who can join

18 and older, female only, with Diabetes, Gestational. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is an urgent need to implement novel diet approaches to combat the increasing rates of gestational diabetes mellitus (GDM). The primary aim of this study is to establish the feasibility of time-restricted eating in pregnancy, to prepare for future larger controlled trials in this research project to determine the efficacy of time-restricted eating in women at risk of GDM. Expectations: 1. Women who have an increased risk of GDM will be able to adhere to time reduced eating during pregnancy. 2. Time reduced eating will improve short-term glycemic control in pregnancy.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Effect of Intermittent Fasting on Appetite: A Systematic Review and Meta-Analysis.
Elsworth RL, Monge A, Perry R, Hinton EC, et al · · 2023 · cited 17× · PMID 37299567 · DOI 10.3390/nu15112604
A randomized feasibility trial of time-restricted eating during pregnancy in people with increased risk of gestational diabetes.
Skarstad HMS, Haganes KL, Sujan MAJ, Gellein TM, et al · · 2024 · cited 8× · PMID 39341847 · DOI 10.1038/s41598-024-72913-y

Verify or expand the search:

Other recruiting trials for Diabetes, Gestational

Currently open trials in the same condition.

NCT05840497 — Effect of Strength-resistance Exercise in the Reduction of Gestational Diabetes in Pregnant Women with Overweight or Obe · NA · recruiting
NCT04542148 — Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes · Phase 2 · active not recruiting
NCT03607799 — A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes · NA · active not recruiting
NCT04060056 — Westlake Precision Birth Cohort · NA · active not recruiting
NCT03681054 — Dietary Management of Gestational Diabetes · NA · active not recruiting

Other Norwegian University of Science and Technology trials

Trials by the same sponsor.

NCT07521891 — Socket-leg Interface Movements in Transtibial Amputees · NA · not yet recruiting
NCT07463001 — Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Munic · NA · not yet recruiting
NCT07422597 — Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prost · NA · recruiting
NCT06558851 — The Effect of Systematic Endurance Training in Treatment of Women With Lipedema · NA · active not recruiting
NCT06893874 — A Pragmatic Trial of Machine Prescription for Migraine · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03803072 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norwegian University of Science and Technology
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03803072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing